FindMyKOL
Clinical trialNCT05207644CompletedPhase 2Interventional

Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation

SponsorGynuity Health ProjectsEnrollment40Pregnancy
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Study to determine if a user-friendly medical abortion regimen using letrozole and misoprostol is safe and acceptable.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Planned Parenthood Salt Lake Health Center

    Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

30 mg letrozole followed by 800 mcg misoprostol
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
9 Dec 2021
Primary completion
30 Apr 2022
Completion
30 Apr 2022
Last update posted
15 Jun 2022
Registered enrollment
40
Registry id
NCT05207644
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.